Acute pancreatitis and hyperamylasemia in renal homograft recipients

Arch Surg. 1972 Aug;105(2):167-72. doi: 10.1001/archsurg.1972.04180080021004.

Abstract

In a series of 301 renal homograft recipients, 17 (5.6%) had acute pancreatitis at some time after transplantation. Eleven of these patients died, for a mortality of 64.7%. In each instance, pancreatitis was a major factor in a complex chain of lethal events to which immunosuppression invariably contributed. An additional 43 patients (14.3%) developed asymptomatic hyperamylasemia after transplantation and, undoubtedly, some of these recipients also had pancreatitis. The factors causing pancreatitis in the renal transplantation patient include uremia, hyperparathyroidism, pancreatic injury by drugs, infections resulting from chronic immunosuppression, gallstones, and operative trauma to the pancreas. In cases of preexisting pancreatitis, transplantation is not necessarily precluded, but efforts should be made to find a specific cause of the pancreatitis and take corrective measures, such as biliary tract surgery or parathyroidectomy if indicated, in advance of transplantation.

MeSH terms

  • Adolescent
  • Adult
  • Amylases / blood*
  • Azathioprine / therapeutic use
  • Calcium / blood
  • Cholelithiasis / complications
  • Creatinine / metabolism
  • Female
  • Humans
  • Hyperparathyroidism / complications
  • Immunosuppressive Agents / adverse effects
  • Infections / complications
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Pancreatitis / blood
  • Pancreatitis / etiology*
  • Postoperative Complications
  • Prednisone / therapeutic use
  • Transplantation Immunology
  • Transplantation, Homologous
  • Uremia / complications

Substances

  • Immunosuppressive Agents
  • Creatinine
  • Amylases
  • Azathioprine
  • Calcium
  • Prednisone